Biotechnology company Vertex Pharmaceuticals (VRTX) reported mixed results for the fourth quarter of 2024. While revenue surpassed analyst ...

RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $407 from $402 and keeps a Sector Perform rating on the shares.

Despite "another impressive quarterly revenue beat" on Tuesday and solid guidance, Vertex stock dipped on light profit.

Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Prayagraj authorities will enforce a No Vehicle Zone in the Mela area and the city from 11 February 2025 for the Maghi Purnima snan at the Mahakumbh. Only essential and emergency vehicles are ...

Leveraging a roster of innovative technical upgrades, the GEN3 Evo unveiled at H.S.H Prince Albert II’s Private Car Collection will debut in Season 11 of the ABB FIA Formula E World Championship.

US President Donald Trump suggested that Ukraine might eventually become part of Russia, ahead of Vice President JD Vance's meeting with Ukrainian President Zelenskyy. Trump emphasized that future ...

Formula E is set to get a lot faster with the introduction of the GEN3 Evo, the quickest accelerating FIA single-seater race car – Capable of 0-60mph in 1.82 seconds (0-100kph in 1.86s). Set to race ...